Controlling HIV has become a major concern within the past decade. The highly diverse spectral range of the infection has created a need for specific treatments at each of these positions. The goal of this group was to provide an insight on various drug therapies that can inhibit the progression of the HIV infection along the spectrum. This information is targeted towards an audience with a small amount of general biology and chemistry background.

Group members include: Laura Soltis, Stephanie Koch, Thomas Razler and Kate Albertson.